0000950131-01-503597.txt : 20011009
0000950131-01-503597.hdr.sgml : 20011009
ACCESSION NUMBER: 0000950131-01-503597
CONFORMED SUBMISSION TYPE: S-8
PUBLIC DOCUMENT COUNT: 3
FILED AS OF DATE: 20010927
EFFECTIVENESS DATE: 20010927
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: LILLY ELI & CO
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: S-8
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-70308
FILM NUMBER: 1746407
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1112
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1112
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
S-8
1
ds8.txt
LILLY GLOBALSHARES STOCK PLAN
As filed with the Securities and Exchange Commission on September __, 2001
Registration No. 333-______
________________________________________________________________________________
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________________________
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
__________________________________
ELI LILLY AND COMPANY
(Exact name of registrant as specified in its charter)
LILLY CORPORATE CENTER
INDIANA INDIANAPOLIS, INDIANA 46285 35-0470950
------- ---------------------------------- -------------------
(State or other (Address of Principal Executive Offices) (I.R.S. Employer
jurisdiction of (Zip Code) Identification No.)
incorporation or
organization)
LILLY GLOBALSHARES STOCK PLAN
(Full Title of the Plan)
------------------------
Rebecca O. Kendall, Senior Vice President and General Counsel
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285
(Name and address of agent for service)
Telephone number, including area code, of agent for service: 317-276-2000
__________________________________
CALCULATION OF REGISTRATION FEE
------------------------------------------------------------------------------------------------------------
Title of Amount to be Proposed maximum Proposed maximum Amount of
securities to be registered offering price per aggregate offering registration fee
registered share (1) price (1)
-------------------------------------------------------------------------------------------------------------
Common Stock 10,900,000 $73.555 $801,749,500 $200,437.37
shares
-------------------------------------------------------------------------------------------------------------
(1) Pursuant to Rule 457(h), these prices are estimated solely for the purpose
of calculating the registration fee and are based upon the average of the high
and low sales prices of Registrant's Common Stock in the consolidated reporting
system on September 21, 2001.
There are also registered hereunder such additional indeterminate number of
shares as may be issued as a result of the antidilution provisions of the Lilly
GlobalShares Stock Plan.
PART I
Item 1. PLAN INFORMATION
Not included pursuant to Form S-8 instructions.
Item 2. REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION
Not included pursuant to Form S-8 instructions.
PART II
Item 3. INCORPORATION OF DOCUMENTS BY REFERENCE
The Annual Report of Eli Lilly and Company (the "Company" or "Registrant") on
Form 10-K for the fiscal year ended December 31, 2000, the Quarterly Reports of
the Company on Form 10-Q for the fiscal quarters ended March 31, 2001, and June
30, 2001 and the description of the Company's common stock contained in the
Company's Registration Statement under the Securities Exchange Act of 1934 with
respect to that stock filed with the Securities and Exchange Commission,
including any amendments or reports filed for the purpose of updating that
description, are incorporated in this Registration Statement by reference. All
documents filed by the Company pursuant to Section 13, 14, or 15(d) of the
Securities Exchange Act of 1934 after the date of this Registration Statement
and prior to the filing of a post-effective amendment which indicates that all
securities offered have been sold or which deregisters all securities then
remaining unsold shall be deemed to be incorporated by reference in this
Registration Statement and to be a part of this Registration Statement from the
date of filing of those documents with the Commission.
Item 4. DESCRIPTION OF SECURITIES
Not applicable.
Item 5. INTERESTS OF NAMED EXPERTS AND COUNSEL
James B. Lootens, Assistant Secretary and Associate General Counsel of the
Company, has provided an opinion as to the legality of the securities offered
hereby. Mr. Lootens beneficially owns 10,838 shares of common stock of the
Company and holds options to purchase an additional 32,775 shares of such stock.
Item 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS
The Indiana Business Corporation Law provides that a corporation, unless limited
by its Articles of Incorporation, is required to indemnify its directors and
officers against reasonable expenses incurred in the successful defense of any
proceeding arising out of their serving as a director or officer of the
corporation.
To the fullest extent permitted by the Indiana Business Corporation Law, the
Company's Articles of Incorporation provide for indemnification of directors,
officers, and employees of the Company against any and all liability and expense
actually and reasonably incurred by them, arising out of any claim or action,
civil, criminal, administrative or investigative, in which they may become
involved by reason of being or having been a director, officer, or employee. To
be entitled to indemnification, (a) those persons must have been wholly
successful in the claim or action on the merits or otherwise or (b) the Board of
Directors, independent legal counsel, or the shareholders must have determined
that such persons acted in good faith in what they reasonably believed to be in
the best interests of the Company (or in the case of conduct not in the
individual's official capacity with the Company, at least not opposed to its
best interests) and, in addition, in any criminal action, had no reasonable
cause to believe that their conduct was unlawful or had reasonable cause to
believe their conduct was lawful.
2
Officers and directors of the Company are insured, subject to certain
exclusions, deductibles and maximum amounts, against loss from claims arising in
connection with their acting in their respective capacities, including claims
under the Securities Act of 1933.
Item 7. EXEMPTION FROM REGISTRATION CLAIMED
Not applicable.
Item 8. EXHIBITS
Exhibit
Number Description
4.1 Articles of Incorporation, as amended
4.2 By-laws, as amended
5 Opinion of James B. Lootens, Assistant Secretary and
Associate General Counsel of the Company, including his
consent
23 Consent of Ernst & Young LLP, Independent Auditors
Item 9. UNDERTAKINGS
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being
made, a post-effective amendment to this Registration
Statement:
(i) To include any prospectus required by section 10(a)(3) of
the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events arising
after the effective date of the Registration Statement (or
the most recent post-effective amendment thereof) which,
individually or in the aggregate, represents a fundamental
change in the information set forth in the Registration
Statement. Notwithstanding the foregoing, any increase or
decrease in volume of securities offered (if the total
dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be
reflected in the form of a prospectus filed with the
Commission pursuant to Rule 424(b) if, in the aggregate,
the changes in volume and price represent no more than a
20 percent change in the maximum aggregate offering price
set forth in the "Calculation of Registration Fee" table
in the effective registration statement;
(iii) To include any material information with respect to the
plan of distribution not previously disclosed in the
Registration Statement or any material change to such
information in the Registration Statement;
Provided, however, that paragraphs (a)(l)(i) and (a)(l)(ii) do not apply if the
Registration Statement is on Form S-3 or Form S-8, and the information required
to be included in a post-effective amendment by those paragraphs is contained in
periodic reports filed by the Registrant pursuant to section 13 or section 15(d)
of the Securities Exchange Act of 1934 that are incorporated by reference in the
Registration Statement.
3
(2) That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall
be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering
thereof.
(3) To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the
termination of the offering.
(b) The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each
filing of the Registrant's annual report pursuant to section 13(a) or
section 15(d) of the Securities Exchange Act of 1934 (and, where
applicable, each filing of an employee benefit plan's annual report
pursuant to section 15(d) of the Securities Exchange Act of 1934)
that is incorporated by reference in the Registration Statement shall
be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering
thereof.
(c) Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that in the
opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act and
is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by
the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any
action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a
court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the
Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Indianapolis, State of Indiana, on September 24,
2001.
ELI LILLY AND COMPANY
By /S/ Sidney Taurel
------------------------------------
Sidney Taurel, Chairman of the Board,
President, and Chief Executive Officer
4
Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed on September 24, 2001, by the following persons in the
capacities indicated.
SIGNATURE TITLE
/s/ Sidney Taurel Chairman of the Board, President,
---------------------------------------- Chief Executive officer, and a
(Sidney Taurel) Director (principal executive
officer)
/s/ Charles E. Golden Executive Vice President,
---------------------------------------- Chief Financial Officer and a
(Charles E. Golden) Director (principal financial
officer)
/s/ Arnold C. Hanish Chief Accounting Officer
---------------------------------------- (principal accounting officer)
(Arnold C. Hanish)
/s/ Steven C. Beering, M.D. Director
----------------------------------------
(Steven C. Beering, M.D.)
/s/ Sir Winfried F. W. Bischoff Director
----------------------------------------
(Sir Winfried F. W. Bischoff)
/s/ George M. C. Fisher Director
----------------------------------------
(George M. C. Fisher)
/s/ Alfred G. Gilman, M.D., Ph.D. Director
----------------------------------------
(Alfred G. Gilman, M.D., Ph.D.)
/s/ Karen N. Horn, Ph.D. Director
----------------------------------------
(Karen N. Horn, Ph.D.)
/s/ Kenneth L. Lay, Ph.D. Director
----------------------------------------
(Kenneth L. Lay, Ph.D.)
/s/ Franklyn B. Prendergast, M.D., Ph.D. Director
----------------------------------------
(Franklyn B. Prendergast, M.D., Ph.D.)
/s/ Kathi P. Seifert Director
----------------------------------------
(Kathi P. Seifert)
/s/ August M. Watanabe Director
----------------------------------------
(August M. Watanabe)
/s/ Alva O. Way Director
----------------------------------------
(Alva O. Way)
5
INDEX TO EXHIBITS
The following documents are filed as part of this Registration Statement:
Exhibit
4.1 Amended Articles of Incorporation, as amended through October 20, 1998/1/
4.2 By-laws, as amended through June 24, 2001/2/
5 Opinion of James B. Lootens, Assistant Secretary and
Associate General Counsel of the Company, including his consent
23 Consent of Ernst & Young LLP, Independent Auditors
_____________________
/1/ Incorporated by reference from Exhibit 3 to the Company's report on Form
10-Q for the quarter ended September 30, 1998.
/2/ Incorporated by reference from Exhibit 3 to the Company's report on Form
10-Q for the quarter ended June 30, 2001.
6
EX-5
3
dex5.txt
OPINION OF JAMES B. LOOTENS
Exhibit 5
September 27, 2001
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285
Gentlemen:
On or about September 27, 2001, Eli Lilly and Company (the "Company") will file
with the Securities and Exchange Commission on Form S-8 its Registration
Statement ("Registration Statement") relating to 10,900,000 shares of Common
Stock that may be issued or transferred by the Company upon the exercise of
stock options or pursuant to stock grants that may be granted to employees of
the Company and its subsidiaries under the Lilly GlobalShares Stock Plan (the
"Plan").
With respect to the Company and shares of its Common Stock, I am of the opinion
that:
A. The Company is a corporation duly organized and validly existing under the
laws of the State of Indiana.
B. The 10,900,000 shares of Common Stock referred to above:
(i) are duly authorized;
(ii) upon selection, in accordance with the terms of the Plan, of
grantees from among those employees of the Company and its
subsidiaries eligible for receipt of stock options and stock grants
("Eligible Employees"), may be validly included in grants of stock
options and stock grants to such Eligible Employees; and
(iii) will be validly issued and outstanding, fully paid and nonassessable
upon issuance or transfer:
(a) pursuant to the due exercise of stock options in accordance
with the terms and subject to the conditions of the Plan and
the payment of the option price stated in such options; and
(b) pursuant to fulfillment of all conditions, if any, required by
the Plan for the issuance or transfer of
1
Eli Lilly and Company
Lilly Corporate Center
September 27, 2001
Page 2
such shares of Common Stock pursuant to stock grants.
In arriving at the foregoing opinions, I have examined corporate records, plans,
agreements and other documents of the Company.
I consent to the use of this opinion as an exhibit to the Registration
Statement. In giving such consent, I do not admit that I come within the
category of persons whose consent is required under Section 7 of the Securities
Act of 1933, as amended, or the Rules and Regulations of the Securities and
Exchange Commission thereunder.
Very truly yours,
/s/ James B. Lootens
JBL:mlc
2
EX-23
4
dex23.txt
CONSENT OF ERNST & YOUNG LLP
Exhibit 23
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement (Form
S-8) pertaining to the Lilly GlobalShares Stock Plan of Eli Lilly and Company of
our report dated January 29, 2001, with respect to the consolidated financial
statements of Eli Lilly and Company incorporated by reference in its Annual
Report (Form 10-K) for the year ended December 31, 2000 filed with the
Securities and Exchange Commission.
/s/ Ernst & Young LLP
Indianapolis, Indiana
September 25, 2001